In conclusion, our study which used the isobolographic method of pharmacological drug–drug interaction analysis demonstrates that the combination of MGN with CDDP could be used in some types of cancer cells to improve their antitumor effects and decrease their doses compared to those administered separately. This evidence concerns the gene HELT and cancer.